Safety evaluation of the trastuzumab biosimilar in Iranian women with HER2-positive breast cancer undergoing adjuvant chemotherapy: a post-marketing surveillance
Zahedi, Fatemeh, Jafari, Anya, Nasiri Motlagh, Behnam, Hamedi, Seyed Hassan, Salek, Roham, Khandoozi, Seyedreza, Farshchian, Negin, Shahidsales, Soodabeh, Mafi, Ahmad R, Hosseini, Sare, Amouheidari, Alireza, Varshoee Tabrizi, Fatemeh, Khanjani, Nezhat, Ahmadloo, Niloofar, Dayyani, Mahdieh, Khodabakhshi, Reza, Mojahed, Mohammad Mahdi, Keshvari, Masoumeh, Fazl Ersi, Mitra, Mirsadraee, Marjaneh, Izadpanahi, Payam, Saadipoor, Afshin, Nasrollahi, Hamid, Anbiaee, Robab, Emadi Torghabeh, Ali, Keramati, Alireza, Amiran, Seyed Ahmadreza, Bayat Mokhtari, Narges, Taghizadeh Kermani, Ali, Anvari, Kazem, Sadeghi Ivari, Mahboobeh, Dayani, Malihe, Amirabadi, Amir, Saeidi Saedi, Hamid, Sabzvari, Araz, Kafi, Hamidreza, Homaei Shandiz, Fatemeh
Published in Expert opinion on drug safety (01.08.2024)
Published in Expert opinion on drug safety (01.08.2024)
Get more information
Journal Article
A Survey on the Prevalence of IVS14 + 1G > A Mutation of the Dihydropyrimidine Dehydrogenase Gene Among a Group of Colorectal Cancer Patients in Northeast Iran, the Relevance of Fluoropyrimidine Based Chemotherapy Toxicity
Salek, Roham, Hosseini, Bibi Ashraf, Behravan, Javad, Aledavood, Amir, Sadeghi Ivari, Mahboobeh
Published in Reports of Radiotherapy and Oncology (31.03.2016)
Published in Reports of Radiotherapy and Oncology (31.03.2016)
Get full text
Journal Article